10.1016/j.jocn.2020.09.054 28 ChecaJ.AranJ
Non-DAC CJC-1295 mimics natural GH secretion and may reduce side effects like water retention or insulin resistance (Crane, N., Frontiers in Endocrinology )
Placebo-Controlled Studies With DPP-4 Inhibition as Monotherapy In drug-nave subjects with type 2 diabetes who were treated with diet and life style, the DPP-4 inhibitors were examined as monotherapy in placebo-controlled 2426 week studies with a total number of 2,328 subjects [Table 2
Description Tesamorelin Ipamorelin CJC-1295 DAC Peptide Combo UK When combined, Tesamorelin and CJC-1295 DAC may synergize for prolonged GH secretion, while Ipamorelin adds pulse-like stimulation without undesirable side effects
Side Effect Profiles Both drugs can cause stomach problems like nausea and vomiting
Discussion Our analysis of Truveta Data reveals notable trends in the prescribing patterns of AOM semaglutide compared to AOM liraglutide, among adolescents aged 12 to 17 years between January 2021 and March 2025